Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
fibromyalgia
Biotech
FDA refuses Axsome filing for former Pfizer fibromyalgia asset
Axsome is plotting another phase 3 trial to make up for a study that the FDA deemed inadequate and not well-controlled.
Darren Incorvaia
Jun 9, 2025 12:27pm
Fecal transplants alleviate fibromyalgia pain in small trial
Apr 28, 2025 7:30am
ElectroCore buys NeuroMetrix and its Quell fibromyalgia wearable
Dec 20, 2024 9:15am
Remedee nabs EU approval for fibromyalgia wristband therapy
Sep 30, 2024 2:00pm
Tonix signs CRO deal, preps FDA app for fibromyalgia drug
Feb 14, 2024 12:52pm
Tonix redirects long COVID med toward fatigue after fail in pain
Sep 5, 2023 9:52am
